The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 18, 2026 | Mohindru Mani | Chief Executive Officer, Director | Buy(P) | 25K | $1.21 | $30K |
| Jun 18, 2026 | Pace Gary W | Director | Buy(P) | 30K | $1.22 | $37K |
| Jun 11, 2026 | Armitage James O | Director | Grant(A) | 41K | — | $0 |
| Jun 11, 2026 | White Lale | Director | Grant(A) | 41K | — | $0 |
| Jun 11, 2026 | Tannenbaum Renee P | Director | Grant(A) | 41K | — | $0 |
| Jun 11, 2026 | Markin Rodney S | Director | Grant(A) | 41K | — | $0 |
| Jun 11, 2026 | Pace Gary W | Director | Grant(A) | 41K | — | $0 |
| Apr 27, 2026 | Aggarwal Ajay | Chief Operating Officer | Grant(A) | 400K | — | $0 |
| Apr 14, 2026 | Smeal Tod | Chief Scientific Officer | Grant(A) | 300K | — | $0 |
| Apr 6, 2026 | Muntner Joshua B | Chief Financial Officer | Grant(A) | 487K | — | $0 |
| Mar 31, 2026 | Mohindru Mani | Chief Executive Officer, Director | Grant(A) | 600K | — | $0 |
| Feb 17, 2026 | Mohindru Mani | Interim CEO, Director | Grant(A) | 200K | — | $0 |
| Feb 13, 2026 | Lindsay Brigitte Ute | Chief Accounting Officer | Grant(A) | 200K | — | $0 |
| Jul 30, 2025 | Pace Gary W | Director | Buy(P) | 275K | $2.45 | $674K |
| Jul 30, 2025 | Pace Gary W | Director | Buy(P) | 15K | $2.45 | $37K |
| Jun 26, 2025 | Pace Gary W | Director | Grant(A) | 41K | — | $0 |
| Jun 26, 2025 | White Lale | Director | Grant(A) | 41K | — | $0 |
| Jun 26, 2025 | Armitage James O | Director | Grant(A) | 41K | — | $0 |
| Jun 26, 2025 | Mohindru Mani | Director | Grant(A) | 41K | — | $0 |
| Jun 26, 2025 | Markin Rodney S | Director | Grant(A) | 41K | — | $0 |
| Jun 26, 2025 | Tannenbaum Renee P | Director | Grant(A) | 41K | — | $0 |
| Mar 11, 2025 | Erlander Mark | Chief Executive Officer, Director | Grant(A) | 758K | — | $0 |
| Mar 11, 2025 | Smeal Tod | Chief Scientific Officer | Grant(A) | 333K | — | $0 |
| Mar 11, 2025 | Levine James E. | Chief Financial Officer | Grant(A) | 333K | — | $0 |
| Mar 11, 2025 | Kabbinavar Fairooz | Chief Medical Officer | Grant(A) | 150K | — | $0 |
| Dec 18, 2024 | Levine James E. | Chief Financial Officer | Buy(P) | 2K | $5.00 | $12K |
| Dec 17, 2024 | Levine James E. | Chief Financial Officer | Buy(P) | 3K | $5.42 | $15K |
| Dec 16, 2024 | Levine James E. | Chief Financial Officer | Buy(P) | 3K | $3.83 | $10K |
| Dec 12, 2024 | Tannenbaum Renee P | Director | Buy(P) | 10K | $3.42 | $34K |
| Dec 11, 2024 | Pace Gary W | Director | Buy(P) | 12K | $2.60 | $30K |
| Dec 11, 2024 | Pace Gary W | Director | Buy(P) | 350K | $2.60 | $910K |
| Jun 27, 2024 | Markin Rodney S | Director | Grant(A) | 30K | — | $0 |
| Jun 27, 2024 | Armitage James O | Director | Grant(A) | 30K | — | $0 |
| Jun 27, 2024 | Pace Gary W | Director | Grant(A) | 30K | — | $0 |
| Jun 27, 2024 | Mohindru Mani | Director | Grant(A) | 30K | — | $0 |
| Jun 27, 2024 | Tannenbaum Renee P | Director | Grant(A) | 30K | — | $0 |
| Jun 27, 2024 | White Lale | Director | Grant(A) | 30K | — | $0 |
| Mar 7, 2024 | Erlander Mark | Chief Executive Officer, Director | Grant(A) | 510K | — | $0 |
| Mar 7, 2024 | Smeal Tod | Chief Scientific Officer | Grant(A) | 205K | — | $0 |
| Mar 7, 2024 | Kabbinavar Fairooz | Chief Medical Officer | Grant(A) | 205K | — | $0 |
| Mar 7, 2024 | Levine James E. | Chief Financial Officer | Grant(A) | 205K | — | $0 |
| Dec 19, 2023 | Pace Gary W | Director | Buy(P) | 30K | $1.37 | $41K |
| Nov 10, 2023 | Pace Gary W | Director | Buy(P) | 23K | $0.98 | $22K |
| Jun 15, 2023 | Tannenbaum Renee P | Director | Grant(A) | 28K | — | $0 |
| Jun 15, 2023 | Mohindru Mani | Director | Grant(A) | 28K | — | $0 |
| Jun 15, 2023 | Pace Gary W | Director | Grant(A) | 28K | — | $0 |
| Jun 15, 2023 | White Lale | Director | Grant(A) | 28K | — | $0 |
| Jun 15, 2023 | Armitage James O | Director | Grant(A) | 28K | — | $0 |
| Jun 15, 2023 | Markin Rodney S | Director | Grant(A) | 28K | — | $0 |
| Mar 15, 2023 | Erlander Mark | Chief Executive Officer, Director | Grant(A) | 482K | — | $0 |
| Mar 15, 2023 | Kelemen Vicki | Exec. VP and COO | Grant(A) | 126K | — | $0 |
| Mar 15, 2023 | Levine James E. | Chief Financial Officer | Grant(A) | 197K | — | $0 |
| Mar 15, 2023 | Smeal Tod | Chief Scientific Officer | Grant(A) | 167K | — | $0 |
| Nov 25, 2022 | Erlander Mark | Chief Executive Officer, Director | Buy(P) | 10K | $1.43 | $14K |
| Sep 19, 2022 | White Lale | Director | Buy(P) | 15K | $1.64 | $25K |
| Sep 16, 2022 | Armitage James O | Director | Buy(P) | 13K | $1.56 | $20K |
| Sep 16, 2022 | Levine James E. | Chief Financial Officer | Buy(P) | 30K | $1.56 | $47K |
| Sep 15, 2022 | Pace Gary W | Director | Buy(P) | 150K | $1.71 | $257K |
| Sep 15, 2022 | Tannenbaum Renee P | Director | Buy(P) | 6K | $1.72 | $11K |
| Sep 15, 2022 | Tannenbaum Renee P | Director | Buy(P) | 4K | $1.72 | $6K |
| Jul 5, 2022 | White Lale | Director | Option exercise(M) | 29K | $2.60 | $75K |
| Jul 5, 2022 | White Lale | Director | Option exercise(M) | 29K | $2.60 | $75K |
| Jun 9, 2022 | Brancaccio John P | Insider | Other(J) | 755 | — | $0 |
| Jun 9, 2022 | Brancaccio John P | Insider | Other(J) | 530 | — | $0 |
| Jun 9, 2022 | Brancaccio John P | Insider | Other(J) | 223 | — | $0 |
| Jun 9, 2022 | Brancaccio John P | Insider | Other(J) | 22K | — | $0 |
| Jun 9, 2022 | Brancaccio John P | Insider | Other(J) | 195 | — | $0 |
| Jun 9, 2022 | Brancaccio John P | Insider | Other(J) | 45K | — | $0 |
| Jun 9, 2022 | Brancaccio John P | Insider | Other(J) | 29K | — | $0 |
| Jun 9, 2022 | Brancaccio John P | Insider | Other(J) | 27K | — | $0 |
| Jun 9, 2022 | Brancaccio John P | Insider | Other(J) | 223 | — | $0 |
| Mar 9, 2022 | Armitage James O | Director | Grant(A) | 27K | — | $0 |
| Mar 9, 2022 | Brancaccio John P | Director | Grant(A) | 27K | — | $0 |
| Mar 9, 2022 | Erlander Mark | Chief Executive Officer, Director | Grant(A) | 370K | — | $0 |
| Mar 9, 2022 | Kelemen Vicki | Exec. VP and COO | Grant(A) | 170K | — | $0 |
| Mar 9, 2022 | Levine James E. | Chief Financial Officer | Grant(A) | 170K | — | $0 |
| Mar 9, 2022 | Markin Rodney S | Director | Grant(A) | 27K | — | $0 |
| Mar 9, 2022 | Mohindru Mani | Director | Grant(A) | 27K | — | $0 |
| Mar 9, 2022 | Ruffner Katherine L | Chief Medical Officer | Grant(A) | 170K | — | $0 |
| Mar 9, 2022 | Tannenbaum Renee P | Director | Grant(A) | 27K | — | $0 |
| Mar 9, 2022 | White Lale | Director | Grant(A) | 27K | — | $0 |
| Mar 9, 2022 | Pace Gary W | Director | Grant(A) | 27K | — | $0 |
| Sep 21, 2021 | Pace Gary W | Director | Buy(P) | 30K | $6.75 | $203K |
| Sep 10, 2021 | Levine James E. | Chief Financial Officer | Buy(P) | 5K | $6.32 | $32K |
| Sep 10, 2021 | Levine James E. | Chief Financial Officer | Buy(P) | 5K | $6.35 | $32K |
| Sep 10, 2021 | Levine James E. | Chief Financial Officer | Buy(P) | 10K | $6.38 | $64K |
| Sep 10, 2021 | Levine James E. | Chief Financial Officer | Buy(P) | 5K | $6.62 | $33K |
| Sep 10, 2021 | Levine James E. | Chief Financial Officer | Buy(P) | 5K | $6.75 | $34K |
| Jul 12, 2021 | Levine James E. | Chief Financial Officer | Grant(A) | 390K | — | $0 |
| Jul 12, 2021 | Ruffner Katherine L | Chief Medical Officer | Grant(A) | 200K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-11. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).